- $1.95bn
- $2.60bn
- $1.10bn
- 38
- 59
- 51
- 48
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 89.67 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.72 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.83 | ||
| EV to EBITDA | 115.63 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3.64% | ||
| Return on Equity | -15.75% | ||
| Operating Margin | -7.12% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | 1,097.39 | 1,266.44 | 1,523.04 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Acuren Corporation is a provider of tech-enabled testing, inspection, certification, and compliance (TICC) services and critical asset integrity solutions. Its operating segments include Inspection and Mitigation, Engineering and Lab, and Geospatial. It supports clients across the full asset lifecycle, from commissioning to compliance, powering its solutions with go-to-market methods, including advanced inspection and nondestructive testing (NDT), Rope Access Technician (RAT) mitigation services, materials engineering services, lab analysis and destructive testing, proprietary software, and drone-enabled geospatial analytics. Its TICC services are mission-critical, frequently compliance-mandated, and typically recurring in nature. NDT activities include inspection and evaluation of industrial equipment through various technology-enabled methods to ensure asset integrity, avoid costly accidents and comply with regulatory requirements without destroying the asset or component.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- December 16th, 2024
- Public Since
- October 12th, 2023
- No. of Shareholders
- 641
- No. of Employees
- 5,498
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
New York Stock Exchange- Shares in Issue
- 198,723,696
- Address
- 14434 Medical Complex Drive, #100, TOMBALL, 77377
- Web
- https://www.acuren.com/
- Phone
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for TIC
Similar to TIC
ABM Industries
New York Stock Exchange
ACCO Brands
New York Stock Exchange
Aris Water Solutions
New York Stock Exchange
BGSF
New York Stock Exchange
Block
New York Stock Exchange
FAQ
As of Today at 19:04 UTC, shares in Acuren are trading at $9.80. This share price information is delayed by 15 minutes.
Shares in Acuren last closed at $9.80 and the price had moved by -3.45% over the past 365 days. In terms of relative price strength the Acuren share price has underperformed the S&P500 Index by -16.85% over the past year.
The overall consensus recommendation for Acuren is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAcuren does not currently pay a dividend.
Acuren does not currently pay a dividend.
Acuren does not currently pay a dividend.
To buy shares in Acuren you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $9.80, shares in Acuren had a market capitalisation of $1.95bn.
Here are the trading details for Acuren:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: TIC
Based on an overall assessment of its quality, value and momentum Acuren is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Acuren is $13.67. That is 39.49% above the last closing price of $9.80.
Analysts covering Acuren currently have a consensus Earnings Per Share (EPS) forecast of -$0.05 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Acuren. Over the past six months, its share price has underperformed the S&P500 Index by -22.71%.
As of the last closing price of $9.80, shares in Acuren were trading -11.58% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Acuren PE ratio based on its reported earnings over the past 12 months is 89.67. The shares last closed at $9.80.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Acuren's directors